Study Shows Low Morbidity, Mortality Rates For Patients Treated With Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy

Researchers at Roswell Park Cancer Institute (RPCI) have determined that cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CS/HIPEC), a complex procedure to treat advanced abdominal cancers, can be done safely, and may be an effective therapy for select patients. Study results are published in the June issue of Cancer Medicine. "There has been much discussion as to whether there is a benefit with this procedure, and historically it has been associated with a lot of risk...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/KIImqnBJ21Y/261853.php

news auto sport medical